Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014

被引:20
作者
Winn, Aaron N. [1 ]
Keating, Nancy L. [2 ]
Trogdon, Justin G. [3 ]
Basch, Ethan M. [3 ,4 ]
Dusetzina, Stacie B. [3 ,4 ,5 ]
机构
[1] Med Coll Wisconsin, Sch Pharm, Dept Clin Sci, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA
[2] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA
[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[4] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA
[5] Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes & Policy, Chapel Hill, NC USA
关键词
D O I
10.1001/jamaoncol.2017.5544
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:580 / 581
页数:2
相关论文
共 5 条
[1]  
Centers for Medicare & Medicaid Services (CMS), 2017, CMS FIN HOSP OUTP PR
[2]  
Higgins A, 2016, AM J MANAG CARE, V22, pE116
[3]   A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients [J].
Klabunde, Carrie N. ;
Legler, Julie M. ;
Warren, Joan L. ;
Baldwin, Laura-Mae ;
Schrag, Deborah .
ANNALS OF EPIDEMIOLOGY, 2007, 17 (08) :584-590
[4]  
Medicare Payment Advisoiy Commission (MedPAC), 2014, REP C MED PAYM POL, P49
[5]   Using the margins command to estimate and interpret adjusted predictions and marginal effects [J].
Williams, Richard .
STATA JOURNAL, 2012, 12 (02) :308-331